[go: up one dir, main page]

KR840007877A - 퀴놀온 카복실 산 및 이들의 화합물을 함유하는 항 박테리아제의 제조방법 - Google Patents

퀴놀온 카복실 산 및 이들의 화합물을 함유하는 항 박테리아제의 제조방법 Download PDF

Info

Publication number
KR840007877A
KR840007877A KR1019840000933A KR840000933A KR840007877A KR 840007877 A KR840007877 A KR 840007877A KR 1019840000933 A KR1019840000933 A KR 1019840000933A KR 840000933 A KR840000933 A KR 840000933A KR 840007877 A KR840007877 A KR 840007877A
Authority
KR
South Korea
Prior art keywords
formula
carbon atoms
optionally
substituted
carboxylic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
KR1019840000933A
Other languages
English (en)
Other versions
KR870000892B1 (ko
Inventor
피터젠(외 4) 우베
Original Assignee
귄터 피터. 칼 루드비히 쉬미트
바이엘 아크티엔 게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 귄터 피터. 칼 루드비히 쉬미트, 바이엘 아크티엔 게젤샤프트 filed Critical 귄터 피터. 칼 루드비히 쉬미트
Publication of KR840007877A publication Critical patent/KR840007877A/ko
Priority to KR1019870002771A priority Critical patent/KR870000894B1/ko
Priority to KR1019870002770A priority patent/KR870000893B1/ko
Application granted granted Critical
Publication of KR870000892B1 publication Critical patent/KR870000892B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

내용 없음.

Description

퀴놀온 카복실 산 및 이들의 화합물을 함유하는 항 박테리아제의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. (a) 일반식(Ⅱ)의 화합물을 일반식(Ⅲ)의 화합물과 반응시키거나, (b) 일반식(Ⅱ)의 화합물을 일반식(Ⅳ)의 이소시아네이트와 반응시키거나 또는, (c) 일반식(Ⅱ)의 화합물을 일반식(Ⅴ)의 무수물과 반응시키는 것을 특징으로 하여, 일반식(Ⅰ)의 퀴놀은 카복실산을 제조하는 방법.
    상기식에서, R1은 라디칼 CO-R6, CN, SO2-R7또는 S-R8이고, R6은 수소, 경우에 따라 치환된 1 내지 6 탄소원자를 갖는 직쇄 또는 측쇄 알킬, 경우에 따라 치환된 6 또는 10탄소원자를 갖는 아릴, 경우에 따라 치환된 아릴 위치에 6 탄소원자를 갖고 알킬 위치에 1 내지 3 탄소원자를 갖는 아르알킬, 경우에 따는 치환된 1 내지 6 탄소원자를 갖는 알콕시 또는 알킬티오, 경우에 따라 치환된 6 탄소원자를 갖는 아릴옥시, 경우에 따라 치환된 벤질옥시, 아미노, 경우에 따라 치환된 알킬 라디칼 속에 1 내지 6탄소원자를 갖는 알킬아미노 또는 디 알킬아미노, 또는 경우에 따라 치환된 페닐 아미노이고, R7은 경우에 따라 치환된 1 내지 5탄소원자를 갖는 직쇄 또는 측쇄 알킬, 페닐 또는 메틸페닐이며, R8은 메톡시카보닐, 트리클로로메틸, 트리플루오로메틸 또는 디 클로로플루오로 메틸이고, R2,R3,R4및 R5는 같거나 또는 다르고 수소, 메틸, 에틸, n-또는 i-프로필이고, X는 수소, 바람직하게는 불소 또는 염소와 같은 할로겐, 또는 질소이다. Y는 바람직하게는 염소, 불소 또는 브롬과 같은 할로겐, 메톡시, 에톡시, 펜옥시, 4-니트로펜옥시 또는 2,3,5-트리클로로펜옥시 또는 알킬카보닐옥시와 같은 이탈 그룹이고, R'는 경우에 따라 치환된 알킬 또는 페닐이며, A는 경우에 따라 치환된 2 또는 3 탄소원자를 갖는 알킬렌 사슬이고 또는 아릴렌 라디칼이다.
  2. 제1항의 일반식(Ⅰ)의 퀴놀은 카복실 산을, 불활성, 비독성, 약제학적으로 적절한 부형제와 혼합하는 것을 특징으로 하여 항 박테리아성 약제를 제조하는 방법.
  3. 제1항의 일반식(Ⅰ)의 퀴놀은 카복실산을 박테리아 감염된 인간 또는 동물에게 투여하는 것을 특징으로 하여 박테리아성 질병을 퇴치하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019840000933A 1983-02-25 1984-02-25 퀴놀론카복실산의 제조방법 Expired KR870000892B1 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1019870002771A KR870000894B1 (ko) 1983-02-25 1987-03-26 퀴놀론 카복실산의 제조방법
KR1019870002770A KR870000893B1 (ko) 1983-02-25 1987-03-26 퀴놀론 카복실산의 제조방법

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3306771.6 1983-02-25
DE19833306771 DE3306771A1 (de) 1983-02-25 1983-02-25 Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel

Related Child Applications (2)

Application Number Title Priority Date Filing Date
KR1019870002771A Division KR870000894B1 (ko) 1983-02-25 1987-03-26 퀴놀론 카복실산의 제조방법
KR1019870002770A Division KR870000893B1 (ko) 1983-02-25 1987-03-26 퀴놀론 카복실산의 제조방법

Publications (2)

Publication Number Publication Date
KR840007877A true KR840007877A (ko) 1984-12-11
KR870000892B1 KR870000892B1 (ko) 1987-05-02

Family

ID=6191896

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840000933A Expired KR870000892B1 (ko) 1983-02-25 1984-02-25 퀴놀론카복실산의 제조방법

Country Status (19)

Country Link
US (1) US4559341A (ko)
EP (1) EP0117473B1 (ko)
JP (1) JPS59163369A (ko)
KR (1) KR870000892B1 (ko)
AT (1) ATE25245T1 (ko)
AU (1) AU563748B2 (ko)
CA (1) CA1246574A (ko)
DE (2) DE3306771A1 (ko)
DK (1) DK103384A (ko)
ES (1) ES530046A0 (ko)
FI (1) FI79702C (ko)
GR (1) GR79989B (ko)
HU (1) HU192399B (ko)
IL (1) IL71037A (ko)
NO (1) NO840558L (ko)
NZ (1) NZ207239A (ko)
PH (2) PH23256A (ko)
PT (1) PT78113B (ko)
ZA (1) ZA841373B (ko)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3306771A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3306772A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinolonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3308909A1 (de) * 1983-03-12 1984-09-13 Bayer Ag, 5090 Leverkusen Bakterizide mittel auf chinoloncarbonsaeure-basis
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
IT1196051B (it) * 1984-03-16 1988-11-10 Schiena Ricerche Composti ad attivita' antibatterica
DE3420770A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-(3-oxo-1-piperazinyl)-3-chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3508816A1 (de) * 1985-01-10 1986-07-10 Bayer Ag, 5090 Leverkusen 6,7-disubstituierte 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphtyridin-3-carbonsaeuren
DE3509546A1 (de) * 1985-03-16 1986-09-25 Bayer Ag, 5090 Leverkusen 7-amino-1-(subst.cyclopropyl)-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4686221A (en) * 1985-10-01 1987-08-11 Kanebo, Ltd. Quinolinecarboxylic acid compounds and antimicrobial agent containing the same
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
EP0224121A3 (en) * 1985-11-19 1987-11-11 ROTTAPHARM S.p.A. 7-[4-amino-piperazinyl]- or 7-[4-chloro-piperazinyl]quinolinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
DE3542002A1 (de) * 1985-11-28 1987-06-04 Bayer Ag 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3601566A1 (de) * 1986-01-21 1987-07-23 Bayer Ag Pharmazeutische zubereitungen von ciprofloxacin
DE3705621C2 (de) * 1986-02-25 1997-01-09 Otsuka Pharma Co Ltd Heterocyclisch substituierte Chinoloncarbonsäurederivate
HU196987B (en) * 1986-10-15 1989-02-28 Chinoin Gyogyszer Es Vegyeszet Process for producing quinoline-carboxylic acid derivatives
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent
SI8712447A8 (en) * 1987-12-31 1995-12-31 Krka Tovarna Zdravil Process for preparing 1-substituted 6-fluoro-4-oxo-7-(1-piperazinyl) -1,4-dihydroquinoline-3-carboxylic acid and new intermediate used in this process
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
FR2676445B1 (fr) * 1991-05-16 1995-02-03 Esteve Labor Dr Derives de pyridone amino acide azetidinyl substitues, leur preparation et leur application en tant que medicaments.
FR2694751B1 (fr) * 1992-08-14 1994-11-25 Bouchara Sa Nouveaux dérivés sulfonamides, leurs procédés de préparation et les compositions en renfermant.
CA2114981A1 (en) 1993-02-09 1994-08-10 Kazumi Ogata Quinolonecarboxylic acid derivatives
US5395936A (en) * 1993-06-04 1995-03-07 Manzo; Ruben H. 7-(4-[4-aminophenyl)sulphonyl]-1-piperazinyl fluorquinolonic derivatives and synthesis
US7842693B2 (en) * 2002-06-12 2010-11-30 Chemocentryx, Inc. Substituted piperazines
US7589199B2 (en) 2002-06-12 2009-09-15 Chemocentryx, Inc. Substituted piperazines
EP1531822B1 (en) 2002-06-12 2009-08-05 ChemoCentryx Inc 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
US20050256130A1 (en) * 2002-06-12 2005-11-17 Chemocentryx, Inc. Substituted piperazines
US7435831B2 (en) * 2004-03-03 2008-10-14 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
AU2005219438B2 (en) * 2004-03-03 2011-02-17 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
US8143398B1 (en) * 2010-02-19 2012-03-27 University Of South Florida Activity of new N-acylated ciprofloxacin derivatives against faculative intracellular bacteria
US9670179B1 (en) * 2013-03-14 2017-06-06 University Of South Florida Antibiotic compositions and methods of use
EP2957561A1 (en) 2014-06-18 2015-12-23 Université Paris 6 Pierre et Marie Curie UPMC Novel fluoroquinolones and use thereof to treat bacterial infections
CN104230889A (zh) * 2014-08-29 2014-12-24 南京大学 环丙沙星衍生物及其制备方法与用途
US11529309B2 (en) * 2016-04-29 2022-12-20 University Of Houston System Compositions, methods and kits for treating a contact lens

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) * 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
JPS5750783B2 (ko) * 1974-02-07 1982-10-28
SE444566B (sv) * 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav
JPS5466686A (en) * 1977-09-20 1979-05-29 Dainippon Pharmaceut Co Ltd Quinoline-3-carboxylic acid derivative, its preparation, and pharmaceutical composition containig the same
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
JPS5845426B2 (ja) * 1978-09-29 1983-10-08 杏林製薬株式会社 置換キノリンカルボン酸誘導体
DE2939783C2 (de) * 1979-10-01 1982-04-29 UOP Inc., 60016 Des Plaines, Ill. Verfahren zum Abscheiden von Schwefel- und Stickstoffoxiden aus einem Gasgemisch
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS5762259A (en) * 1980-09-05 1982-04-15 Kyorin Pharmaceut Co Ltd Preparation of substituted quinolinecarboxylic acid derivative
EP0090424B1 (en) * 1982-03-31 1986-05-28 Sterling Drug Inc. New quinolone compounds and preparation thereof
DE3306772A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinolonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3306771A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel

Also Published As

Publication number Publication date
PT78113B (en) 1986-04-30
IL71037A0 (en) 1984-05-31
AU563748B2 (en) 1987-07-23
NO840558L (no) 1984-08-27
AU2428484A (en) 1984-08-30
PT78113A (en) 1984-03-01
KR870000892B1 (ko) 1987-05-02
FI79702B (fi) 1989-10-31
GR79989B (ko) 1984-10-31
US4559341A (en) 1985-12-17
DK103384A (da) 1984-08-26
CA1246574A (en) 1988-12-13
DK103384D0 (da) 1984-02-24
PH23248A (en) 1989-06-16
ZA841373B (en) 1984-10-31
FI840748A0 (fi) 1984-02-23
HU192399B (en) 1987-06-29
PH23256A (en) 1989-06-16
ATE25245T1 (de) 1987-02-15
DE3306771A1 (de) 1984-08-30
FI79702C (fi) 1990-02-12
JPS59163369A (ja) 1984-09-14
IL71037A (en) 1988-02-29
DE3462255D1 (en) 1987-03-05
ES8500932A1 (es) 1984-11-01
NZ207239A (en) 1986-05-09
ES530046A0 (es) 1984-11-01
EP0117473B1 (de) 1987-01-28
EP0117473A1 (de) 1984-09-05
FI840748L (fi) 1984-08-26

Similar Documents

Publication Publication Date Title
KR840007877A (ko) 퀴놀온 카복실 산 및 이들의 화합물을 함유하는 항 박테리아제의 제조방법
FI892787A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-indolyylialkyyli-4-(substituoitu pyridinyyli)piperatsiinien valmistamiseksi
EP0610958A3 (en) Intermediates for the preparation of derivatives of 4-oxoquinoline-3-carboxylic acid.
ATE238983T1 (de) Herstellung einer substituierten 2,5-diamino-3- hydroxyhexan
KR920018011A (ko) N-아실-α-아미노산 유도체
GR3022113T3 (en) Pyrazolopyridine compounds and processes for preparation thereof
AU657106B2 (en) Preparation and use of N-iodopropargyl oxycarbonyl amino acid esters and derivatives as antimicrobial agents
AU2736088A (en) Pharmaceutical compositions comprising benzylidene- and cinnamylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novel compounds and their preparation
ATE10192T1 (de) Substituierte imidazol-derivate, deren herstellung und verwendung.
NZ214156A (en) Quindone derivatives and pharmaceutical compositions
DE69021855D1 (de) Quinazolinderivate und ihre Herstellung.
FI845047A0 (fi) Antipsoriatisk naftalenfoerening.
SE8105689L (sv) Terapeutiska medel
EP0555479A4 (ko)
EP0205299A3 (en) Isatin derivatives, compositions containing the same, and the use thereof for ulcer diseases
ES2010225A6 (es) Procedimiento de preparacion de nuevos derivados de piperazina diona-2,6.
DE3561948D1 (en) Oximinophosphoric acid derivatives, process for their preparation and their use as pesticides
FR2674436B1 (fr) Nouvelle utilisation de sterouides 4,9,11-trieniques dans des compositions destinees a l'administration chez la dinde.
EP0218195A3 (en) Bis(dibenzo[b,d]pyranyloxy)propanes
KR960031439A (ko) 치환 인돌 유도체
KR910000774A (ko) 앙골라마이신 유도체, 그의 제조방법 및 용도

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

FPAY Annual fee payment

Payment date: 19900501

Year of fee payment: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19910503

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19910503

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000